Use of Chk2 kinase inhibitors for cancer treatment

Details for Australian Patent Application No. 2006275679 (hide)

Owner Government of the United states of America, as represented by the Secretary, Department of Health and Human Services

Inventors Jobson, Andrew; Pommier, Yves; Currens, Michael; Cardelina, John; Shoemaker, Robert H.; Scudiero, Dominic

Agent Pizzeys

Pub. Number AU-B-2006275679

PCT Pub. Number WO2007/016338

Priority 60/703,556 29.07.05 US

Filing date 27 July 2006

Wipo publication date 8 February 2007

Acceptance publication date 12 April 2012

International Classifications

A61K 31/17 (2006.01) - having the group NC(O)N or NC(S)N, e.g. urea, thiourea, carmustine

A61K 31/175 (2006.01)

A61K 31/4184 (2006.01)

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

21 February 2008 PCT application entered the National Phase

  PCT publication WO2007/016338 Priority application(s): WO2007/016338

12 April 2012 Application Accepted

  Published as AU-B-2006275679

9 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006275682-Flocked articles incorporating a porous film

2006275670-Apparatus and method for placing an implant in vivo